Exscientia | Investor Presentation Deck | 76 slides · page 31 of 76
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).
Pitch deck · roadmap · plan_implementation · overcrowded density
Slide locked Sign in to view
Slide schematic 7/7
diagram 1/1 disclaimer 1/1 list 2/2 paragraph 1/1 title 2/2
Components 7
timeline disclaimer bullet bullet paragraph action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1